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ABSTRACT
To analyze the short and long-term out-
come of patients aged 65 years and over, af-
ter cardiac surgery. Over a 12-year period 
we analyzed 1750 patients with a mean age 
of 70.09   3.94 years. They were classified 
into three age groups: between 65 and 69 
(n = 709), between 70 and 74 (n = 695) 
and 75 years and above (n = 346). Follow-
up information was obtained by telephone 
conversation after a 6-month and 3-year 
period of discharge from the hospital. In-
cluded in the follow-up were 1235 patients 
and an interview was conducted with 501 
(40.6%) patients or their next of kin. 
Even though the in-hospital morbidity was 
highest in the oldest age group, there were 
no significant differences between groups 
(p = 0.051). There was no significant dif-
ference between groups in the length of 
hospital stay. The greatest in-hospital mor-
tality was noted in the oldest age group (p 
= 0.046) compared to patients in the age 
groups between 65 and 69 and between 
70 and 74 years old (p = 0.023 and p = 
0.036). In the follow-up study, there was 
a significantly smaller telephone feedback 
response in the oldest age group compared 
to the youngest group (p = 0.003). There 
were no differences between the groups 
with respect to mortality and cardiac death 
after the 6-month and 3-year periods of 
discharge from hospital. 
Our data showed that despite a poor short 
– and long-term outcome in patients aged 
75 and over, all patients had an acceptable 
operative risk.   
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INTRODUCTION
According to the Croatian Bureau of Sta-
tistics, in the year 2011 there were 4 284 
889 citizens in Croatia with a portion of 
those aged 65 and over at 17.7 % (in 2001 
it was at 15.7%) (1). Furthermore, in 2016 
there were 4 154 213 citizens in Croatia 
with a portion of those aged 65 and over 
increased at 19.6% (2). 
From the statistics above, it can be seen 
that the Croatian population is rapidly 
aging and is marked by a significantly ad-
vanced age. The age index derived from the 
number of citizens aged 65 years and above 
in comparison to the age group of  0 – 14 
years of age was 116.3 (in 2001 it was 91.9), 
which means that for the first time in the 
history of Croatia, in 2011 there were more 
senior citizens than those of a younger age 
(1,3).
Longer life expectancy has lead to in-
creased incidence of cardiovascular dis-
ease, the primary cause of morbidity and 
mortality in the elderly. This represents a 
special challenge for cardiac surgery in the 
population above 65 years of age. Com-
monly, cardiac surgery in the elderly is 
associated with a higher risk of death and 
longer hospital stay which leads many pa-
tients to question the feasibility of such 
procedures. Contrary to this, advances 
in anesthetic and surgical techniques, as 
well as improved perioperative care, have 
resulted in a significant improvement in 
short and long-term outcomes after open 
heart surgery in the elderly (4,5). 
The purpose of this study was to determine 
the short-term clinical outcome (in-hos-
pital mortality and morbidity) in patients 
who underwent elective cardiac surgery 
and were aged 65 years and above. Follow-
up information about their long-term 
outcome was obtained from telephone 
conversations after a 6-month and 3-year 
period of discharge from the hospital. 
PATIENTS AND METHODS
Over a 12-year period (between January 
1998 and December 2009) patients aged 
65 years and above, who underwent elec-
tive coronary and valve open-heart sur-
gery were included in this retrospective 
observational study. The computerized 
database "CardioBase“ of the Department 
of Cardiac Surgery and Transplantation at 
University Hospital Dubrava Zagreb, was 
used to identify 1750 consecutive patients. 
All other types of cardiac surgery, except 
coronary and valve surgery, were not in-
cluded in the study such as urgent surgery 
and revision. The study was compiled in 
accordance with the Declaration of Helsin-
ki. No specific written conset was acquired 
for this study since all cardiac surgical pa-
tients' data were anonymous. 
All patients received standard premedi-
cation with morphine in dose of 0.1 mg/
kg IM (Morphine Merck®, Merck KgaA, 
Darmstadt, Germany) and other of their 
cardiac medications one hour before sur-
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gery. Anesthesia induced with midazolam 
(Dormicum®, F. Hoffman-La Roche Ltd., 
Basel, Switzerland) 0.1 mg/kg IV, fentanyl 
(Fentanyl® Janssen Pharmaceutica, Beerse, 
Belgium) 5-7 μg/kg IV, and pancuronium-
bromide (Pavulon®, N.V. Organon, Oss, 
the Netherlands) 0.1 mg/kg IV. After en-
dotracheal intubation, the lungs were me-
chanically ventilated using positive pres-
sure (tidal volume 8 mL/kg, ventilatory 
frequency 12/min) (Cato, Dräger, Lübeck, 
Germany). Anesthesia was maintained 
with a nitrous-oxide mixture (60% oxygen 
and 40% nitrous oxide) and sevoflurane 
(Sevorane®, Abbott Laboratories S.A., Ab-
bott Park, IL, USA) in doses of 1-1.5 mini-
mal alveolar concentration (MAC). ASA 
standard monitors were applied and arte-
rial and venous catheters were inserted to 
measured pressures and  cardiac output on 
admission to the operating room. 
Moderate hypothermia (32-34 °C) or 
normothermia was maintained during 
cardiopulmonary bypass (CBP - hepar-
ing-coated circuit) with composition of 
priming volume: infusol solution 1200 
ml (Pliva, Zagreb, Croatia), mannitol 20% 
250 ml (Croatian Institute of Transfusion 
Medicine, Zagreb, Croatia), human albu-
min 20% 100 ml (Institute of Immunol-
ogy, Zagreb, Croatia) and heparin sodium 
10,000 I.U. (Belupo, Koprivnica, Croatia). 
Myocardial perfusion during aortic cross 
clamping (ACC) was obtained by cold 
blood cardioplegia strategy (a modified 
Gerald Buckberg solution mixture was a 
4:1 oxygenated blood to crystalloid ratio) 
to achieve cardiac arrest. Activated clotting 
time (ACT) was maintained greater than 
480 seconds for CPB. Starting dose of hep-
arin 300 units/kg was reversed with prota-
mine sulfate (Fresenius Kabi, Lake Zurich, 
IL, USA) in a 1 to 1-1.5 ratio. The target 
mean arterial pressure was 60 mmHg dur-
ing CPB and 60 – 80 mmHg after CPB. Af-
ter surgery, patients were transferred to the 
ICU. Criteria for hospital discharge includ-
ed hemodynamic and rhythm stability, an 
afebrile condition with the absence of sur-
gical incision site infection and feeding. 
The patients were classified into three 
cohorts. The first group (n = 709) was 
between 65 and 69 years old, the second 
group (n = 695) was between 70 and 74 
years old and the third group (n = 346) was 
aged 75 years and above. The mean age of 
patients, which included 1201 men and 
549 women, was 70.09   3.94 years (range 
65 to 87). The mean logistic EuroSCORE 
of the 1750 patients was 5.42 ± 2.49 (Ta-
ble 1). The observed parameters were in-
hospital morbidity, mortality and length of 
hospital stay. 
Follow-up was conducted through conver-
sation either with the patient or the next 
of kin by telephone. It was related to the 
two observed periods: the 6-month and 
the 3-year period, of discharge from the 
hospital. A pre-planned questionnaire in-
cluded the time and cause of death where 
warranted. The telephone conversations 
were carried out between March and Oc-
tober of 2017. In the case where there was 
no answer to the phone calls, a further 
two calls were made in the following three 
weeks. The follow-up study included 1750 
patients and an interview was conducted 
with  only 711 (40.6%)  patients or the next 
of kin by telephone. 
For data analysis, the SAS System for Win-
dows Release 9.4 software (SAS Institute 
Inc., Cary, NC, USA) was used. Numerical 
data were expressed as mean   the stand-
ard deviation. Quantitative variables were 
analyzed for the normality of distribution 
using the Kolmogorov-Smirnov test. Qual-
itative data were described by frequencies. 
To compare the three independent groups, 
categoric variables were analyzed using the 
two-tailed Pearson χ2 test. To compare the 
three independent groups, continuous var-
iables which were not normally distributed 
were analyzed using the Kruskal-Wallis 
test. To find differences between the three 
groups, we tested the groups in pairs by the 
Mann-Whitney test corrected for multiple 
testing. All statistical values were consid-
ered significant at p < 0.05.
RESULTS
Preoperative and operative data of the 
study are shown in Table 1. Demograph-
ics and preoperative data were similar 
between three groups except for Euro-
Score where all three groups mutually sig-
nificantly differ (p < 0.001 for all). Coro-
nary artery bypass grafting (CABG) was 
performed in 1036 patients. Out of 1036 
coronary patients, 476 patients (45.9%) 
Table 1. Preoperative and operative data
Variable Patients
65-69 years (n=709)
mean ± SD
 70-74 years (n=695)  
mean ± SD
75 and above (n=346)
mean ±  SD
P-value†
Preoperative data
Sex    M (n)
          F  (n)
Diabetes mellitus (n)
Hypertension (n)
Ejection fraction (%)
EuroSCORE 
507
202
116 
311 
56.96 ± 11.65
4.64 ± 2.33
469
226
120 
285 
 55.90 ± 11.86
5.46 ± 2.32
225
121
46 
134 
56.19 ± 11.65
6.66 ± 2.42
0.073
0.253
0.252
0.412‡
< 0.001‡
Operative data
CABG/OPCABG (n)
Valve (n)
Valve and CABG (n)
CPB (min)
ACCT (min)
455/203
153
101
107.19 ± 50.52
65.81 ± 28.10
395/186
180
120
110.97 ± 48.70
67.97 ± 31.03
186/87
93
67
113.96 ± 46.69
70.65 ± 30.36
0.002
0.183
0.087
0.026‡
0.095‡
Data expressed as mean and standard deviation (SD). CABG – coronary artery bypass grafting, OPCABG – coronary artery bypass 
grafting without cardiopulmonary bypass,     CPB – cardiopulmonary bypass, ACCT – aortic cross clamp time. 
†comparison between groups with Pearson χ2 test;  
‡comparison between groups with Kruskal-Wallis test.
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underwent coronary artery bypass graft-
ing without cardiopulmonary bypass (OP-
CABG). Valve surgery was performed in 
429 patients, and concomitant procedures 
of CABG and valve surgery in 287 patients. 
A significantly greater number of patients 
underwent coronary surgery in the young-
est age group in comparison to the other 
two groups (p = 0.007 and p = 0.001). The 
duration of  CPB was significantly longer 
in the oldest age group compared to the 
youngest group (p = 0.007). Although aor-
tic cross clamp time was the longest in the 
oldest age group, there were no significant 
differences between groups (Table 1). 
There were no significant differences be-
tween the groups in terms of prolonged 
mechanical ventilation, incidence of perio-
perative myocardial infarction, low cardiac 
output syndrome, stroke, acute kidney in-
jury (AKI), sepsis and multiple organ dys-
function syndrome. Even though hospital 
morbidity was greatest in the oldest age 
group, there were no significant differenc-
es between the groups (p = 0.051). There 
was no significant difference between the 
groups in length of hospital stay. A signifi-
cantly greater mortality was noted in the 
oldest age group compared to the other 
two groups (p = 0.023 and p = 0.036) (Ta-
ble 2). 
In the follow-up study, a significantly 
smaller response to the phone interview 
was noted in the oldest group compared to 
the youngest age group (p = 0.003). There 
were no differences between the groups 
with respect to mortality and cardiac death 
after the 6-month and the 3-year periods of 
discharge from the hospital (Table 3). 
DISCUSSION
According to the Croatian Bureau of Sta-
tistics, from 2011 until today, there have 
been more senior citizens aged 65 years 
and above than those of a younger age 
(1,2). Also, today's population in Europe 
is rapidly ageing. The need for cardiac 
surgery in elderly patients is rising and a 
growing number of cardiac patients are 
presented with coronary heart disease and 
degenerative valve disease. This is the first 
retrospective observational report assess-
ing the results of elective cardiac surgery 
in patients aged 65 and above, categorized 
into three age groups. Over a 12-year pe-
riod, from the database, 1750 consecutive 
patients from 65 to 87 years  of age were 
identified, with the mean age of patients 
being 70. 
Table 2. Short-term outcome (in-hospital mortality and morbidity)
Variable Patients
65-69 years (n=709)
%
70-74 years (n=695) 
%
 75 and above (n=346)
%
P-value†
Morbidity (n)   77 (10.9) 97 (14.0) 55 (15.9) 0.051
Prolonged MV (n) 28 (3.9) 21 (3.0) 20 (5.8) 0.200
Perioperative MI (n)* 17 (2.4) 17 (2.4) 14 (4.0) 0.372
LCOS (n) 15 (2.1) 16 (2.3) 10 (2.9) 0.658
CVI (n) 12 (1.7) 16 (2.3) 11 (3.2) 0.303
AKI (n) 11 (1.6) 10 (1.4) 6 (1.7) 0.936
Sepsis (n) 22 (3.1) 35 (5.0) 14 (4.0) 0.186
MODS (n) 12 (1.7) 13 (1.9) 12 (3.5) 0.144
Length of stay (days) 17.49 ± 10.52 18.12 ± 10.78 18.48 ± 12.30 0.418
Hospital mortality (n) 39 (5.5) 40 (5.8) 32 (9.2) 0.046‡
Data expressed as percent (%), mean and standard deviation (SD). MI* – myocardial infarction include patients undergoing coronary 
and valvular surgery, MV – mechanical ventilation, LCOS – low cardiac output syndrome, CVI – cerebrovascular insult or stroke, 
MODS – multiple organ dysfunction syndrome, AKI – acute kidney injury. 
†comparison between groups with Pearson χ2 test;  
‡comparison between groups with Kruskal-Wallis test.
Table 3. Long-term outcome 
Variable Patients
65-69 years (n=709)
%
70-74 years (n=695)
%
75 and above (n=346)
%
P-value†
Response to telephone call (n)* 328 (46.2) 270 (38.8) 103 (29.7) 0.001
Follow up to 6 months
Mortality (n)  12 (3.7) 9 (3.3) 8 (7.8) 0.198
Cardiac death (n) 7 (2.1) 6 (2.2) 7 (6.8) 0.115
Follow up to 3 years
Mortality (n) 32 (9.8) 30 (11.1) 15 (14.6) 0.545
Cardiac death (n) 17 (5.2) 16 (5.9) 5 (4.9) 0.929
†comparison between groups with Pearson χ2 test;  
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Older patients have different cardiac dis-
eases, more comorbidities and are usu-
ally referred later for surgery (4). In our 
study, the youngest age group of patients, 
between 65 and 69 years old, more com-
monly suffered from hypertension, while 
patients between 70 and 74 years of age, 
more often suffered from diabetes mel-
litus. The logistic EuroSCORE was used 
to stratify patients, since it is known to 
be the most accurate predictor of death 
in high risk cases (6). It seems to overesti-
mate mortality at lower score levels (Euro-
SCORE ≤ 6) and underestimate mortality 
at higher score levels (EuroSCORE > 13) 
(7). Sündermann et al. (8) report 30-day 
mortality of 5.5% in 400 cardiac surgical 
patients ≥ 74 years with EuroSCORE 8.5, 
while in our the oldest age group mortal-
ity was 9.2% with EuroSCORE 6.7 (Table 1 
and 2). On the other side, none of prognos-
tic model for predicting mortality in elder-
ly intensive care patients can be currently 
considered sufficiently valid to be appro-
priate in our clinical practice (9) (Table 1). 
Anesthesiological protocol was the same 
throughout an operative period. A cardio-
pulmonary bypass for elective cardiac sur-
gery is instituted with linear flow about 2.5 
L/min/m2 and myocardial protection was 
performed using cold blood cardioplegia 
solution. Patients in the age group of 75 
years and above, had a greater in-hospital 
mortality (9.2%) compared to the other 
two groups (p = 0.051). Some studies show 
a different incidence of in-hospital mortal-
ity in octogenerians undergoing cardiac 
surgery (from 6.5% to 9.2%) (10,11). The 
oldest age group of patients was on me-
chanical ventilation for a longer period 
of time, but without significance in com-
parison to the other two groups. Prolonged 
mechanical ventilation is classified as post-
operative ventilation continued for more 
than 24 hours (12,13). In the same group, 
there was an increased incidence of perio-
perative myocardial infarction (4.0%), low 
cardiac output (2.9%), stroke (3.2%) and 
acute kidney injury (1.7%), but without 
significance. Baskett et al. (10) reports 
higher incidence of stroke (4.7%) in octo-
generians undergoing CABG compared to 
the age group of 75 years and above. Vives 
et al. (14) showed a greater incidence of 
AKI (defined as a rise in serum creatinine 
>1 mg/dl above baseline) at 2.5% in pa-
tients after CABG and at 2.8% after valvu-
lar surgery compared to our patients with 
AKI at 1.5%. Sepsis and multiple organ 
dysfunction syndrome, as a progressive 
organ dysfunction in an acutely ill patient, 
were more common in the oldest age group 
but without significance in comparison to 
the other age groups (15,16). This group of 
patients had one day longer length of hos-
pital stay (18.5 days) compared to the other 
two groups (Table 2). In another retrospec-
tive investigation, Kolh et al. (17) reported 
an incidence of hospital mortality at 13% 
in 182 consecutive eighty-year-old patients 
after cardiac surgery and their length of 
hospital stay were 18.8 days. 
Prospective data on long-term outcome 
were obtained by telephone conversa-
tion with the patient or the nearest kin. 
Follow-up showed that besides the num-
ber of years of life after surgery per se, 
for the older patients, the quality of life is 
a second important parameter. There has 
been no doubt that elderly patients who 
undergo cardiac surgery have an improve-
ment in their quality of life (18,19). Our 
follow-up questionnaire had not included 
questions about symptoms following sur-
gery and other questions about the qual-
ity of life, but included two observational 
periods and causes of death, whether 
they were of cardiac or noncardiac cause. 
Overall the patient response to the tel-
ephone interview was 40.6% and was sig-
nificantly smaller in the oldest age group 
(29.7%). The most common reason for not 
responding were a change in phone num-
ber or address. The total mortality rate of 
the 711 interviewed patients amounted to 
4.1% after the 6-month and 10.8% after the 
3-year period of discharge from the hos-
pital. The most common cause of mortal-
ity was cardiac death after both observed 
periods, after 6-months (in 68.9% of cases) 
and after 3-years (in 49.3% of cases). Even 
though the greatest mortality after both the 
6-month and 3-year periods of discharge 
from the hospital was in the oldest age 
group (7.8% and 14.6%), there were no dif-
ferences between the groups (Table 3). One 
retrospective study shows an incidence of 
long-term survival after three years  in the 
octogenarians undergoing cardiac surgery 
at 79.1% (15). Previous reports had shown 
that in spite of a relatively higher morbidity 
and mortality when compared with young-
er patients, elderly patients have an ac-
ceptable operative risk, and the long-term 
results are pleasing (20,21). The TIME 
study presented the greater improvement 
of quality of life in patients older than 75 
who underwent CABG regardless of their 
greater perioperative risk, compared to 
those with non-surgical treatment (22). 
Even though this study included a large 
number of patients, limitations of study 
contain the weakness, inherent to any 
retrospective study. The study covers an 
extended period of time which the perio-
perative management of cardiac surgical 
patients may have been in some measure 
changed. In the follow-up study, despite 
three telephone calls made to every patient, 
nevertheless there was a poor response rate 
from the patients to the interview. Fur-
thermore, we did not analyze the actual 
survival rate after surgery or the quality of 
life of patients by a questionnaire after hos-
pital discharge, which is something that 
could be included in a future study, with 
important implications on long-term out-
come. At last, comparison to age-matched 
population of patients with the same car-
diac abnormalities, who were eligible for 
surgery is a theoretical option, but it would 
be difficult to perform.
In conclusion, we have confirmed that de-
spite a poor short and long-term outcome 
in patients aged 75 and over, all patients 
aged 65 years and above after elective car-
diac surgery, have a satisfactory operative 
risk in our clinical setting.  
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